Distinct Subtypes of Apathy Revealed by the Apathy Motivation Index

Yuen-Siang Ang, Patricia Lockwood, Matthew A J Apps, Kinan Muhammed, Masud Husain, Yuen-Siang Ang, Patricia Lockwood, Matthew A J Apps, Kinan Muhammed, Masud Husain

Abstract

Apathy is a debilitating but poorly understood disorder characterized by a reduction in motivation. As well as being associated with several brain disorders, apathy is also prevalent in varying degrees in healthy people. Whilst many tools have been developed to assess levels of apathy in clinical disorders, surprisingly there are no measures of apathy suitable for healthy people. Moreover, although apathy is commonly comorbid with symptoms of depression, anhedonia and fatigue, how and why these symptoms are associated is unclear. Here we developed the Apathy-Motivation Index (AMI), a brief self-report index of apathy and motivation. Using exploratory factor analysis (in a sample of 505 people), and then confirmatory analysis (in a different set of 479 individuals), we identified subtypes of apathy in behavioural, social and emotional domains. Latent profile analyses showed four different profiles of apathy that were associated with varying levels of depression, anhedonia and fatigue. The AMI is a novel and reliable measure of individual differences in apathy and might provide a useful means of probing different mechanisms underlying sub-clinical lack of motivation in otherwise healthy individuals. Moreover, associations between apathy and comorbid states may be reflective of problems in different emotional, social and behavioural domains.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Apathy Motivation Index (AMI) factor…
Fig 1. Apathy Motivation Index (AMI) factor model.
The factor analysis identified three distinct subscales, namely behavioural activation (BA), social motivation (SM) and emotional sensitivity (ES). BA relates to an individual’s tendency to self-initiate goal-directed behaviour, SM examines a person’s engagement of social interactions and ES probes an individual’s feelings of positive and negative affection. While SM correlated with BA and ES, BA did not associate with ES. (**: p < 0.01).
Fig 2. Correlation coefficients between AMI subscales…
Fig 2. Correlation coefficients between AMI subscales and established measures of depression, anhedonia and fatigue.
BA and SM correlated positively with BDI and MFIS, indicating that individuals that were more apathetic on these subscales also had higher levels of depression and fatigue. In contrast the ES scale was negatively correlated with depression and fatigue. All three AMI subscales were negatively correlated with the SHAPS (lower scores indicate higher levels of anhedonia), suggesting that higher apathy was associated with lower hedonia.
Fig 3. Distribution of apathy along the…
Fig 3. Distribution of apathy along the AMI subscales and conditional response means of the 4-class solution.
The AMI consists of three subscales: Behavioural Activation, Social Motivation and Emotional Sensitivity. Every subscale contains 6 items that is each scored from 0–4, with a higher mean score indicating greater apathy. (A) 3D scatterplot illustrating the distribution of each healthy individual’s mean rating along the three AMI subscales. The four classes were labelled generally motivated (orange), behaviourally/socially apathetic (green), emotionally apathetic (blue), and generally apathetic (red). (B) Conditional response mean value greater than overall sample means (black line) indicates apathy on that AMI subscale.
Fig 4. Relationships between apathy subtype and…
Fig 4. Relationships between apathy subtype and depression, anhedonia and fatigue.
The four apathy-motivation subtypes were predictive of different associations with depression (A), anhedonia (B) and fatigue (C). The behaviourally/socially apathetic experienced the greatest depression and fatigue while the generally motivated were most hedonic. (* p < 0.05, ** p < 0.01, *** p < 0.001).

References

    1. Marin RS. Apathy: a neuropsychiatric syndrome. J Neuropsychiatry Clin Neurosci. 1991;3(3):243–54. 10.1176/jnp.3.3.243
    1. Levy R, Dubois B. Apathy and the Functional Anatomy of the Prefrontal Cortex-Basal Ganglia Circuits. Cereb Cortex. 2006;16(7):916–28. 10.1093/cercor/bhj043
    1. Pagonabarraga J, Kulisevsky J, Strafella AP, Krack P. Apathy in Parkinson’s disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol. 2015. May;14(5):518–31. 10.1016/S1474-4422(15)00019-8
    1. Muhammed K, Husain M. Clinical significance of apathy in Parkinson’s disease. EMJ Neurol. 4(1):56–63.
    1. Bonnelle V, Manohar S, Behrens T, Husain M. Individual Differences in Premotor Brain Systems Underlie Behavioral Apathy. Cereb Cortex. 2015. November 12;bhv247.
    1. Landes AM, Sperry SD, Strauss ME, Geldmacher DS. Apathy in Alzheimer’s disease. J Am Geriatr Soc. 2001. December;49(12):1700–7.
    1. Kiang M, Christensen BK, Remington G, Kapur S. Apathy in schizophrenia: clinical correlates and association with functional outcome. Schizophr Res. 2003. September;63(1–2):79–88.
    1. Kirsch-Darrow L, Fernandez HH, Marsiske M, Okun MS, Bowers D. Dissociating apathy and depression in Parkinson disease. Neurology. 2006. July 11;67(1):33–8. 10.1212/01.wnl.0000230572.07791.22
    1. Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, Avarello TP, et al. The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson’s disease. Mov Disord Off J Mov Disord Soc. 2009. August 15;24(11):1641–9.
    1. Vansteenkiste M, Lens W, De Witte S, De Witte H, Deci EL. The“why” and“why not” of job search behaviour: their relation to searching, unemployment experience, and well-being. Eur J Soc Psychol. 2004. May;34(3):345–63.
    1. Vansteenkiste M, Lens W, De Witte H, Feather NT. Understanding unemployed people’s job search behaviour, unemployment experience and well-being: a comparison of expectancy-value theory and self-determination theory. Br J Soc Psychol Br Psychol Soc. 2005. June;44(Pt 2):268–87.
    1. Marin RS, Biedrzycki RC, Firinciogullari S. Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res. 1991. August;38(2):143–62.
    1. Sockeel P, Dujardin K, Devos D, Deneve C, Destee A, Defebvre L. The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2006. May 1;77(5):579–84. 10.1136/jnnp.2005.075929
    1. Radakovic R, Abrahams S. Developing a new apathy measurement scale: Dimensional Apathy Scale. Psychiatry Res. 2014. November;219(3):658–63. 10.1016/j.psychres.2014.06.010
    1. Pluck GC, Brown RG. Apathy in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2002. December 1;73(6):636–42. 10.1136/jnnp.73.6.636
    1. Skorvanek M, Gdovinova Z, Rosenberger J, Ghorbani Saeedian R, Nagyova I, Groothoff JW, et al. The associations between fatigue, apathy, and depression in Parkinson’s disease. Acta Neurol Scand. 2015. February;131(2):80–7. 10.1111/ane.12282
    1. Kirsch-Darrow L, Marsiske M, Okun MS, Bauer R, Bowers D. Apathy and Depression: Separate Factors in Parkinson’s Disease. J Int Neuropsychol Soc. 2011. November;17(6):1058–66. 10.1017/S1355617711001068
    1. Lieberman A. Depression in Parkinson’s disease—a review. Acta Neurol Scand. 2006. January;113(1):1–8. 10.1111/j.1600-0404.2006.00536.x
    1. Leentjens AFG, Dujardin K, Marsh L, Martinez-Martin P, Richard IH, Starkstein SE, et al. Apathy and anhedonia rating scales in Parkinson’s disease: Critique and recommendations. Mov Disord. 2008. October 30;23(14):2004–14. 10.1002/mds.22229
    1. Cochrane GD, Rizvi S, Abrantes AM, Crabtree B, Cahill J, Friedman JH. The association between fatigue and apathy in patients with either Parkinson’s disease or multiple sclerosis. Parkinsonism Relat Disord. 2015. September;21(9):1093–5. 10.1016/j.parkreldis.2015.07.007
    1. Bonnelle V, Veromann K-R, Burnett Heyes S, Lo Sterzo E, Manohar S, Husain M. Characterization of reward and effort mechanisms in apathy. J Physiol-Paris. 2015. February;109(1–3):16–26. 10.1016/j.jphysparis.2014.04.002
    1. Muthen LK, Muthen BO. Mplus User’s Guide. Seventh Edition Los Angeles, CA: Muthen & Muthen; 1998.
    1. Cattell RB. The Scree Test For The Number Of Factors. Multivar Behav Res. 1966. April;1(2):245–76.
    1. Hu L, Bentler PM. Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives. Struct Equ Model Multidiscip J. 1999. January;6(1):1–55.
    1. Worthington RL, Whittaker TA. Scale Development Research: A Content Analysis and Recommendations for Best Practices. Couns Psychol. 2006. November 1;34(6):806–38.
    1. Beck AT, Steer RA, Ball R, Ranieri WF. Comparison of Beck Depression Inventories-IA and-II in Psychiatric Outpatients. J Pers Assess. 1996. December;67(3):588–97. 10.1207/s15327752jpa6703_13
    1. Snaith RP, Hamilton M, Morley S, Humayan A, Hargreaves D, Trigwell P. A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry. 1995. July 1;167(1):99–103.
    1. Franken IHA, Rassin E, Muris P. The assessment of anhedonia in clinical and non-clinical populations: Further validation of the Snaith–Hamilton Pleasure Scale (SHAPS). J Affect Disord. 2007. April;99(1–3):83–9. 10.1016/j.jad.2006.08.020
    1. Multiple Sclerosis Council for Clinical Practice Guidelines. Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Washington (DC): Paralyzed Veterans of America; 1998. 33 p.
    1. Hoekstra RA, Vinkhuyzen AAE, Wheelwright S, Bartels M, Boomsma DI, Baron-Cohen S, et al. The Construction and Validation of an Abridged Version of the Autism-Spectrum Quotient (AQ-Short). J Autism Dev Disord. 2011. May;41(5):589–96. 10.1007/s10803-010-1073-0
    1. Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J R Stat Soc Ser B Methodol. 1995;57(1):289–300.
    1. McLachlan GJ, Peel D. Finite mixture models. New York: Wiley; 2000. 419 p. (Wiley series in probability and statistics. Applied probability and statistics section).
    1. Lo Y, Mendell NR, Rubin DB. Testing the number of components in a normal mixture. Biometrika. 2001. October 1;88(3):767–78.
    1. Akaike H. A new look at the statistical model identification. IEEE Trans Autom Control. 1974. December;19(6):716–23.
    1. Schwarz G. Estimating the Dimension of a Model. Ann Stat. 1978. March;6(2):461–4.
    1. Stuss DT. Functions of the Frontal Lobes: Relation to Executive Functions. J Int Neuropsychol Soc. 2011. September;17(5):759–65. 10.1017/S1355617711000695
    1. Brown RG, Pluck G. Negative symptoms: the “pathology” of motivation and goal-directed behaviour. Trends Neurosci. 2000. September;23(9):412–7.
    1. Everitt BJ, Robbins TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci. 2005. November;8(11):1481–9. 10.1038/nn1579

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren